Patents by Inventor John D. Dobak

John D. Dobak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110208271
    Abstract: Described are apparatus and methods for electrically modulating a nerve in a mammal. An electrical signal that includes a signal intensity pattern and a signal frequency pattern is delivered to a nerve. The combination of the signal intensity pattern and the signal frequency pattern is effective to result in weight loss, fat loss, and/or lean-mass gain, in a mammal. In some embodiments the nerve is modulated in response to a physiological parameter. In some embodiments, the physiological parameter is measured by a sensor.
    Type: Application
    Filed: April 28, 2011
    Publication date: August 25, 2011
    Inventor: John D. Dobak
  • Patent number: 7937145
    Abstract: Described are apparatus and methods for electrically modulating a nerve in a mammal. An electrical signal that includes a signal intensity pattern and a signal frequency pattern is delivered to a nerve. The combination of the signal intensity pattern and the signal frequency pattern is effective to result in weight loss, fat loss, and/or lean-mass gain, in a mammal. In some embodiments the nerve is modulated in response to a physiological parameter. In some embodiments, the physiological parameter is measured by a sensor.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: May 3, 2011
    Assignee: Advanced Neuromodulation Systems, Inc.
    Inventor: John D. Dobak
  • Patent number: 7829554
    Abstract: Compositions, formulations, methods, and systems for treating regional fat deposits comprise contacting a targeted fat deposit with a composition comprising long acting beta-2 adrenergic receptor agonist and a compound that reduces desensitization of the target tissue to the long acting beta-2 adrenergic receptor agonist, for example, glucocorticosteroids and/or ketotifen. Embodiments of the composition are administered, for example, by injection, and/or transdermally.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: November 9, 2010
    Assignee: Lithera, Inc.
    Inventor: John D. Dobak
  • Publication number: 20100241189
    Abstract: A tissue modulation device, for treating at least one of obesity, metabolic syndrome, and Type 2 diabetes in a patient, is described. In some embodiments, the device includes a storage module having computer-readable instructions for delivering an electrical stimulation pattern to a splanchnic nerve of the patient. The stimulation pattern includes at least one on-time. The on-time includes at least one of a suprathreshold period and a subthreshold period. The splanchnic nerve is selected from the group consisting of the greater splanchnic nerve, the lesser splanchnic nerve, and the least splanchnic nerve. The pattern is effective to ameliorate at least one attendant condition of obesity, metabolic syndrome, and Type 2 diabetes in the patient. The attendant condition includes dyslipidemia, hypertension, hyperinsulinemia, hyperglycemia, and/or insulin resistance.
    Type: Application
    Filed: February 12, 2010
    Publication date: September 23, 2010
    Applicant: Advanced Neuromodulation Systems, Inc.
    Inventors: John D. Dobak, Hans Neisz
  • Patent number: 7702386
    Abstract: The disclosure provides a description of a tissue modulation device, for treating at least one of obesity, metabolic syndrome, and Type 2 diabetes in a patient. In some embodiments, the device includes a storage module having computer-readable instructions for delivering an electrical stimulation pattern to a splanchnic nerve of the patient. The stimulation pattern includes at least one on-time. The on-time includes at least one of a suprathreshold period and a subthreshold period. The splanchnic nerve is selected from the group consisting of the greater splanchnic nerve, the lesser splanchnic nerve, and the least splanchnic nerve. The pattern is effective to ameliorate at least one attendant condition of obesity, metabolic syndrome, and Type 2 diabetes in the patient. The attendant condition includes dyslipidemia, hypertension, hyperinsulinemia, hyperglycemia, and/or insulin resistance.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: April 20, 2010
    Assignee: Leptos Biomedical, Inc.
    Inventors: John D. Dobak, Hans Neisz
  • Patent number: 7689276
    Abstract: A method for the treatment of obesity or other disorders by electrical activation or inhibition of nerves is disclosed. This activation or inhibition can be accomplished by stimulating a nerve using an electrode. Dynamic stimulation through ramped cycling of electrical stimulation, stimulation frequency alteration, and/or duty cycle variance can produce therapeutic benefits.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: March 30, 2010
    Assignee: Leptos Biomedical, Inc.
    Inventor: John D. Dobak
  • Publication number: 20090118777
    Abstract: Methods and devices providing for bilateral stimulation of left and right splanchnic nerves. Some embodiments of the method increase satiety, reduce appetite, affect gastric motility, and/or reduce food intake, resulting in weight loss. Some methods provided take advantage of anatomy, physiology, and natural body time periods to change stimulation locations and patterns to prevent the body from ignoring the administered stimulation signals in order to continue to induce weight loss over long time periods.
    Type: Application
    Filed: August 2, 2008
    Publication date: May 7, 2009
    Inventors: Kobi IKI, John D. DOBAK, Hans NEISZ
  • Publication number: 20080262411
    Abstract: A method for the treatment of obesity or other disorders by electrical activation or inhibition of nerves is disclosed. This activation or inhibition can be accomplished by stimulating a nerve using an electrode. The method further comprises performing a surgical procedure and/or administering a weight loss drug.
    Type: Application
    Filed: June 2, 2006
    Publication date: October 23, 2008
    Inventor: John D. Dobak
  • Publication number: 20080221651
    Abstract: The use of an intravascular cooling element to induce hypothermia in connection with a medical procedure. According to a first aspect of the present, invention, a coronary bypass procedure is conducted in which a patient's blood is oxygenated with the patient's lungs and in which blood is circulated using the patient's heart or using an intracorporeal pump. The procedure preferably comprises: (a) positioning a heat transfer element in a blood vessel of a patient; (b) cooling the body of the patient to less than 35° C., more preferably 32±2° C., using the heat transfer element; and (c) forming a fluid communicating graft between an arterial blood supply and the coronary artery. The body of the patient is preferably heated to about 37° C. using the heat transfer element subsequent to the step of forming the fluid communicating graft.
    Type: Application
    Filed: May 13, 2008
    Publication date: September 11, 2008
    Applicant: Innercool Therapies, Inc.
    Inventor: John D. Dobak
  • Publication number: 20040267250
    Abstract: An enhanced method and device are provided to treat atrial fibrillation or inhibit or reduce restenosis following angioplasty or stent placement. A balloon-tipped catheter is disposed in the area treated or opened through balloon angioplasty immediately following angioplasty. The balloon, which can have a dual balloon structure, may be delivered through a guiding catheter and over a guidewire already in place. A fluid such as a perfluorocarbon flows into the balloon to freeze the tissue adjacent the balloon, this cooling being associated with reduction of restenosis. A similar catheter may be used to reduce atrial fibrillation by inserting and inflating the balloon such that an exterior surface of the balloon contacts at least a partial circumference of the portion of the pulmonary vein adjacent the left atrium. In another embodiment, blood perfusion is performed simultaneously.
    Type: Application
    Filed: July 15, 2004
    Publication date: December 30, 2004
    Inventors: Steven A. Yon, John D. Dobak, Hans W. Kramer, Stephen R. Cooper, Rebecca S. Inderbitzen
  • Publication number: 20040230265
    Abstract: An endovascular heat transfer device which can have a smooth exterior surface, or a surface with ridges and grooves. The device can have a plurality of elongated, articulated segments, with each having such a surface. A flexible joint connects adjacent elongated, articulated segments. The flexible joints can be bellows or flexible tubes. An inner lumen is disposed within the heat transfer segments. The inner lumen is capable of transporting a pressurized working fluid to a distal end of the heat transfer element.
    Type: Application
    Filed: March 8, 2004
    Publication date: November 18, 2004
    Applicant: Innercool Therapies, Inc.
    Inventors: John D. Dobak, Juan C. Lasheras, Randell L. Werneth
  • Publication number: 20040230255
    Abstract: A method for the treatment of obesity or other disorders by electrical activation or inhibition of the sympathetic nervous system is disclosed. This activation or inhibition can be accomplished by stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an electrode. This nerve activation can result in reduced food intake and increased energy expenditure.
    Type: Application
    Filed: February 24, 2004
    Publication date: November 18, 2004
    Inventor: John D. Dobak
  • Publication number: 20040230264
    Abstract: A heat transfer device has first and second elongated, articulated segments, each having a turbulence-inducing exterior surface. A flexible joint connects the first and second elongated, articulated segments. An inner coaxial lumen is disposed within the first and second elongated, articulated segments. The inner coaxial lumen is capable of transporting a pressurized working fluid to a distal end of the first elongated, articulated segment.
    Type: Application
    Filed: December 29, 2003
    Publication date: November 18, 2004
    Inventors: John D. Dobak, Juan C. Lasheras
  • Publication number: 20040153133
    Abstract: An endovascular heat transfer device which can have a smooth exterior surface, or a surface with ridges and grooves. The device can have a plurality of elongated, articulated segments, with each having such a surface. A flexible joint connects adjacent elongated, articulated segments. The flexible joints can be bellows or flexible tubes. An inner lumen is disposed within the heat transfer segments. The inner lumen is capable of transporting a pressurized working fluid to a distal end of the heat transfer element.
    Type: Application
    Filed: January 23, 2004
    Publication date: August 5, 2004
    Applicant: Innercool Therapies, Inc.
    Inventors: John D. Dobak, Juan C. Lasheras, Randell L. Werneth
  • Publication number: 20040106969
    Abstract: A catheter system and method are provided which change the temperature of a fluid, such as blood, by heat transfer. Selective cooling or heating of an organ may be performed by changing the temperature of the blood feeding the organ. The catheter system includes an inlet lumen and an outlet lumen structured and arranged to carry a working fluid having a temperature different from the adjacent blood. The outlet lumen is configured to induce turbulence in the adjacent fluid passing adjacent the outlet lumen.
    Type: Application
    Filed: November 14, 2003
    Publication date: June 3, 2004
    Applicant: Innercool Therapies, Inc.
    Inventors: John D. Dobak, Juan D. Lasheras
  • Publication number: 20040087934
    Abstract: The present invention provides an enhanced method and device to inhibit or reduce the rate of restenosis following angioplasty or stent placement. The invention involves placing a balloon tipped catheter in the area treated or opened through balloon angioplasty immediately following angioplasty. The balloon, which can have a dual balloon structure, may be delivered through a guiding catheter and over a guidewire already in place from a balloon angioplasty. A fluid such as a perfluorocarbon may be flowed into the balloon to freeze the tissue adjacent the balloon, this cooling being associated with reduction of restenosis. The catheter may also be used to reduce atrial fibrillation by inserting and inflating the balloon such that an exterior surface of the balloon is in contact with at least a partial circumference of the portion of the pulmonary vein adjacent the left atrium.
    Type: Application
    Filed: June 26, 2003
    Publication date: May 6, 2004
    Applicant: Innercool Therapies, Inc.
    Inventors: John D. Dobak, Hans W. Kramer, Steve A. Yon
  • Publication number: 20040068311
    Abstract: A guidable catheter for heating or cooling a surrounding fluid in a feeding vessel in a vasculature of a patient. The catheter includes a heat transfer element, the heat transfer element having a plurality of exterior surface irregularities shaped and arranged to create turbulence in a surrounding fluid. The surface irregularities have a depth at least equal to the boundary layer thickness of flow of the surrounding fluid in the feeding vessel. The catheter assembly also includes a supply catheter having a portion disposed within the heat transfer element to deliver a working fluid to an interior of the heat transfer element. The catheter assembly further includes a return catheter to return a working fluid from the interior of the heat transfer element. A guidewire tube is provided adjacent one of the supply catheter or the return catheter and runs substantially parallel to the axis of the guidable catheter to receive a guidewire disposed within the guidewire tube.
    Type: Application
    Filed: April 3, 2003
    Publication date: April 8, 2004
    Inventors: John D. Dobak, Juan C. Lasheras, Randell L. Werneth
  • Publication number: 20030187489
    Abstract: A device and method for providing body cooling for treating fever. The cooling device applies cooling to blood flowing in a vein or artery, e.g., the vena cavae, that is then distributed throughout the body.
    Type: Application
    Filed: April 9, 2003
    Publication date: October 2, 2003
    Applicant: Innercool Therapies, Inc.
    Inventors: John D. Dobak, Steven A. Yon, Michael Magers
  • Publication number: 20030181959
    Abstract: A method for the treatment of obesity or other disorders, by wireless electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by wirelessly stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using a wireless electrode inductively coupled with a radiofrequency field. The source of radiofrequency energy may be internal or external to the patient. This nerve activation can result in reduced food intake and increased energy expenditure.
    Type: Application
    Filed: October 16, 2002
    Publication date: September 25, 2003
    Inventor: John D. Dobak
  • Publication number: 20030181958
    Abstract: A method for the treatment of obesity or other disorders, by electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by electrically stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an implantable pulse generator. This nerve activation can result in reduced food intake and increased energy expenditure. Reduced food intake may occur through a variety of mechanisms that reduce appetite and cause satiety. Increased adrenal gland hormone levels will result in increased energy expenditure. Fat and carbohydrate metabolism, which are also increased by sympathetic nerve activation, will accompany the increased energy expenditure.
    Type: Application
    Filed: September 13, 2002
    Publication date: September 25, 2003
    Inventor: John D. Dobak